Ibio Inc
General ticker "IBIO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $22.3M
Ibio Inc follows the US Stock Market performance with the rate: 43.7%.
Estimated limits based on current volatility of 4.3%: low 2.31$, high 2.52$
Factors to consider:
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-06-30 to 2025-06-29
- 2023-06-30 to 2024-06-29 estimated range: [4.69$, 19.67$]
- 2024-06-29 to 2025-06-29 estimated range: [2.22$, 8.77$]
Financial Metrics affecting the IBIO estimates:
- Negative: Non-GAAP EPS, $ of -32.97 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -77.42 <= 2.35
- Negative: negative Net income
- Negative: Inventory ratio change, % of 33.15 > 1.08
- Negative: Industry operating cash flow per share per price (median), % of -19.26 <= 3.85
- Negative: Industry operating profit margin (median), % of -100 <= 2.14
Short-term IBIO quotes
Long-term IBIO plot with estimates
Financial data
| YTD | 2021-06-30 | 2022-06-30 | 2023-06-30 |
|---|---|---|---|
| Operating Revenue | $2.37MM | $1.88MM | $0.00MM |
| Operating Expenses | $33.48MM | $31.58MM | $29.34MM |
| Operating Income | $-31.11MM | $-29.70MM | $-29.34MM |
| Non-Operating Income | $7.90MM | $0.10MM | $0.03MM |
| Interest Expense | $2.45MM | $1.41MM | $0.00MM |
| R&D Expense | $9.99MM | $17.73MM | $10.33MM |
| Income(Loss) | $-23.21MM | $-29.60MM | $-29.31MM |
| Taxes | $0.00MM | $-0.09MM | $0.00MM |
| Other Income(Loss) | $0.00MM | $-20.79MM | $-35.70MM |
| Profit(Loss) | $-23.21MM | $-50.30MM | $-65.01MM |
| Stockholders Equity | $108.58MM | $63.48MM | $15.38MM |
| Inventory | $0.03MM | $3.90MM | $21.09MM |
| Assets | $146.97MM | $99.41MM | $41.21MM |
| Operating Cash Flow | $-30.06MM | $-37.48MM | $-30.44MM |
| Capital expenditure | $5.16MM | $11.63MM | $5.74MM |
| Investing Cash Flow | $-26.48MM | $-5.13MM | $7.01MM |
| Financing Cash Flow | $78.83MM | $-6.12MM | $2.30MM |
| Earnings Per Share* | $-59.45 | $-116.97 | $-47.87 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.